A CT-based radiomics tumor quality and quantity model to predict early recurrence after radical surgery for colorectal liver metastases.

IF 2.8 3区 医学 Q2 ONCOLOGY
Clinical & Translational Oncology Pub Date : 2025-03-01 Epub Date: 2024-08-17 DOI:10.1007/s12094-024-03645-8
Sunya Fu, Dawei Chen, Yuqin Zhang, Xiao Yu, Lu Han, Jiazi Yu, Yupeng Zheng, Liang Zhao, Yidong Xu, Ying Tan, Mian Yang
{"title":"A CT-based radiomics tumor quality and quantity model to predict early recurrence after radical surgery for colorectal liver metastases.","authors":"Sunya Fu, Dawei Chen, Yuqin Zhang, Xiao Yu, Lu Han, Jiazi Yu, Yupeng Zheng, Liang Zhao, Yidong Xu, Ying Tan, Mian Yang","doi":"10.1007/s12094-024-03645-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to develop a tumor radiomics quality and quantity model (RQQM) based on preoperative enhanced CT to predict early recurrence after radical surgery for colorectal liver metastases (CRLM).</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 282 cases from 3 centers. Clinical risk factors were examined using univariate and multivariate logistic regression (LR) to construct the clinical model. Radiomics features were extracted using the least absolute shrinkage and selection operator (LASSO) for dimensionality reduction. The LR learning algorithm was employed to construct the radiomics model, RQQM (radiomics-TBS), combined model (radiomics-clinical), clinical risk score (CRS) model and tumor burden score (TBS) model. Inter-model comparisons were made using area under the curve (AUC), decision curve analysis (DCA) and calibration curve. Log-rank tests assessed differences in disease-free survival (DFS) and overall survival (OS).</p><p><strong>Results: </strong>Clinical features screening identified CRS, KRAS/NRAS/BRAF and liver lobe distribution as risk factors. Radiomics model, RQQM, combined model demonstrated higher AUC values compared to CRS and TBS model in training, internal and external validation cohorts (Delong-test P < 0.05). RQQM outperformed the radiomics model, but was slightly inferior to the combined model. Survival curves revealed statistically significant differences in 1-year DFS and 3-year OS for the RQQM (P < 0.001).</p><p><strong>Conclusions: </strong>RQQM integrates both \"quality\" (radiomics) and \"quantity\" (TBS). The radiomics model is superior to the TBS model and has a greater impact on patient prognosis. In the absence of clinical data, RQQM, relying solely on imaging data, shows an advantage in predicting early recurrence after radical surgery for CRLM.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"1198-1210"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-024-03645-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aimed to develop a tumor radiomics quality and quantity model (RQQM) based on preoperative enhanced CT to predict early recurrence after radical surgery for colorectal liver metastases (CRLM).

Methods: A retrospective analysis was conducted on 282 cases from 3 centers. Clinical risk factors were examined using univariate and multivariate logistic regression (LR) to construct the clinical model. Radiomics features were extracted using the least absolute shrinkage and selection operator (LASSO) for dimensionality reduction. The LR learning algorithm was employed to construct the radiomics model, RQQM (radiomics-TBS), combined model (radiomics-clinical), clinical risk score (CRS) model and tumor burden score (TBS) model. Inter-model comparisons were made using area under the curve (AUC), decision curve analysis (DCA) and calibration curve. Log-rank tests assessed differences in disease-free survival (DFS) and overall survival (OS).

Results: Clinical features screening identified CRS, KRAS/NRAS/BRAF and liver lobe distribution as risk factors. Radiomics model, RQQM, combined model demonstrated higher AUC values compared to CRS and TBS model in training, internal and external validation cohorts (Delong-test P < 0.05). RQQM outperformed the radiomics model, but was slightly inferior to the combined model. Survival curves revealed statistically significant differences in 1-year DFS and 3-year OS for the RQQM (P < 0.001).

Conclusions: RQQM integrates both "quality" (radiomics) and "quantity" (TBS). The radiomics model is superior to the TBS model and has a greater impact on patient prognosis. In the absence of clinical data, RQQM, relying solely on imaging data, shows an advantage in predicting early recurrence after radical surgery for CRLM.

Abstract Image

基于CT的放射组学肿瘤质量和数量模型,用于预测结直肠肝转移根治术后的早期复发。
目的:本研究旨在开发一种基于术前增强 CT 的肿瘤放射组学质量和数量模型(RQQM),以预测结直肠肝转移瘤(CRLM)根治术后的早期复发:方法:对3个中心的282例病例进行了回顾性分析。采用单变量和多变量逻辑回归(LR)分析临床风险因素,构建临床模型。使用最小绝对收缩和选择算子(LASSO)提取放射组学特征,以降低维度。采用 LR 学习算法构建放射组学模型、RQQM(放射组学-TBS)、组合模型(放射组学-临床)、临床风险评分(CRS)模型和肿瘤负荷评分(TBS)模型。使用曲线下面积(AUC)、决策曲线分析(DCA)和校准曲线进行模型间比较。对数秩检验评估了无病生存期(DFS)和总生存期(OS)的差异:临床特征筛选确定 CRS、KRAS/NRAS/BRAF 和肝叶分布为风险因素。在训练队列、内部和外部验证队列中,放射组学模型、RQQM、组合模型的AUC值均高于CRS和TBS模型(Delong-test P 结论:RQQM整合了 "放射组学 "和 "TBS "两个模型:RQQM 综合了 "质"(放射组学)和 "量"(TBS)。放射组学模型优于 TBS 模型,对患者预后的影响更大。在缺乏临床数据的情况下,RQQM 仅依靠影像学数据,在预测 CRLM 根治术后早期复发方面显示出优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信